Myelodysplastic Syndromes (MDS): A Group of Diseases

Daniel Pollyea, MD, MS

Please join us as we speak to Dr. Daniel Pollyea from the University of Colorado School of Medicine.  In this episode, Dr. Pollyea discusses the group of diseases that make up Myelodysplastic Syndromes (MDS) and how their variability leads to different treatments and prognoses, from active monitoring to chemotherapy and/or stem cell transplantation.  He shares his excitement about new treatment advances and is looking forward to an era of innovative targeted treatments for MDS.

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode provided by Taiho Oncology.


  1. I listened to this podcast and found it exceptionally helpful. I have MDS and had a BMT I am doing well. I appreciated hearing about the scoring. I am a NP so have increased interest personally and professionally.

Leave a Comment

Your email address will not be published. Required fields are marked *